Workflow
BioRestorative Therapies(BRTX) - 2024 Q1 - Quarterly Report

For the Three Months Ended March 31, 2023 Series B Convertible Additional Preferred Stock Common Stock Paid-In Accumulated Shares Amount Shares Amount Capital Deficit Total | --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------------------------------|-----------|------------|-----------|-------|-------|--------------|----------------|---------------| | Return and cancellation of shares in lieu of payroll tax \nwithholding | - | - | (10,058) ...